Cause‐specific mortality in HPV+ and HPV− oropharyngeal cancer patients: insights from a population‐based cohort
Open Access
- 24 November 2017
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 7 (1) , 87-94
Abstract
Identifying the causes of death in head and neck cancer patients can optimize follow‐up and therapeutic strategies, but studies in oropharyngeal squamous cell carcinoma (OPSCC) patients stratified by HPV status are lacking. We report cause‐specific mortality in a population‐based cohort of patients with OPSCC. Patients who had been diagnosed with OPSCC (n = 1541) between 2000 and 2014 in eastern Denmark were included in the study. Causes of death were collected through medical files and the Danish National Cause of Death registry. Deaths were grouped as (1) primary oropharyngeal cancer, (2) secondary malignancies, (3) cardiovascular and pulmonary disease, or (4) other/unspecified. The cumulative incidence of death and specific causes of death were determined using risk analysis. At follow‐up, 723 (47.5%) patients had died. The median time to and cause of death were determined: oropharyngeal cancer (n = 432; 1.00 year), secondary malignancies (n = 131; 2.37 years), cardiovascular and pulmonary causes (n = 58; 3.48 years), and unspecified causes (n = 102; 3.42 years). HPV/p16 status was the strongest predictor of improved survival across all causes of death. The only cause of death to decrease in incidence over the 2 years after treatment was death from OPSCC. HPV/p16 positivity was an independent factor for improved survival across all causes of death in patients with OPSCC. In addition, both HPV‐positive and HPV‐negative OPSCC patients faced high 5‐ and 10‐year mortality rates. Implementing secondary screening and prevention strategies for late toxicity and mortality are major goals in managing the treatment of these patients.Keywords
Funding Information
- Villadsen Family Foundation
- Candy’s Foundation
- Kraeftfonden (The Cancer Foundation)
This publication has 76 references indexed in Scilit:
- Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersThe Lancet Oncology, 2014
- Causes of death in long‐term survivors of head and neck cancerCancer, 2014
- Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic reviewBritish Journal of Cancer, 2014
- Competing causes of death in patients with oropharyngeal cancer treated with radiotherapyExperimental and Therapeutic Medicine, 2012
- The Danish Register of Causes of DeathScandinavian Journal of Public Health, 2011
- Trends in head and neck cancer incidence in Denmark, 1978–2007: Focus on human papillomavirus associated sitesInternational Journal of Cancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Mortality and Causes of Death After Multimodality Treatment for Advanced Oral and Oropharyngeal CancerJournal of Oral and Maxillofacial Surgery, 2007
- Death certification in patients whose primary treatment for oral andoropharyngeal carcinoma was operation: 1992–1997British Journal of Oral and Maxillofacial Surgery, 2001